Tsveta Milanova

This profile gathers the share dealings of Tsveta Milanova in Agios Pharmaceuticals, Inc. We count 16 filings; the first trade dates from 28 June 2023 and the latest from 2 April 2026.

On the market, this insider has only sold: 5 sales, €314k in total. The rest of the record consists of 11 option exercises. 2026 to date brings no purchases and 3 sales.

The latest filing, published on 6 April 2026, reports an open-market sale of €98k in Agios Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.